Michael Krawczak
Overview
Explore the profile of Michael Krawczak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
9874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Qiao J, Levinson R, Chen B, Engelter S, Erhart P, Gaynor B, et al.
Front Genet
. 2023 Jul;
14:1166972.
PMID: 37485343
Most methods to detect copy number variation (CNV) have high false positive rates, especially for small CNVs and in real-life samples from clinical studies. In this study, we explored a...
12.
Aleknonyte-Resch M, Trinh J, Leonard H, Delcambre S, Leitao E, Lai D, et al.
NPJ Parkinsons Dis
. 2023 Jun;
9(1):102.
PMID: 37386035
The effects of one genetic factor upon Parkinson's disease (PD) risk may be modified by other genetic factors. Such gene-gene interaction (G×G) could explain some of the 'missing heritability' of...
13.
Shi Y, Strobl R, Apfelbacher C, Bahmer T, Geisler R, Heuschmann P, et al.
Infection
. 2023 May;
51(6):1679-1694.
PMID: 37231313
Purpose: We aimed to assess symptoms in patients after SARS-CoV-2 infection and to identify factors predicting prolonged time to symptom-free. Methods: COVIDOM/NAPKON-POP is a population-based prospective cohort of adults whose...
14.
Wehkamp K, Krawczak M, Schreiber S
Dtsch Arztebl Int
. 2023 May;
120(27-28):463-469.
PMID: 37218054
Background: Artificial intelligence (AI) is increasingly being used in patient care. In the future, physicians will need to understand not only the basic functioning of AI applications, but also their...
15.
Koch S, Schmidtke J, Krawczak M, Caliebe A
J Community Genet
. 2023 May;
14(5):471-487.
PMID: 37133683
Since their first appearance in the context of schizophrenia and bipolar disorder in 2009, polygenic risk scores (PRSs) have been described for a large number of common complex diseases. However,...
16.
Sharma A, Junge O, Szymczak S, Ruhlemann M, Enderle J, Schreiber S, et al.
Front Genet
. 2023 Feb;
14:1048312.
PMID: 36755569
Inflammatory bowel disease (IBD) is characterized by a dysbiosis of the gut microbiome that results from the interaction of the constituting taxa with one another, and with the host. At...
17.
Hartung T, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al.
EClinicalMedicine
. 2022 Sep;
53:101651.
PMID: 36133318
Background: Reliable estimates of frequency, severity and associated factors of both fatigue and cognitive impairment after COVID-19 are needed. Also, it is not clear whether the two are distinct sequelae...
18.
Schons M, Pilgram L, Reese J, Stecher M, Anton G, Appel K, et al.
Eur J Epidemiol
. 2022 Jul;
37(8):849-870.
PMID: 35904671
The German government initiated the Network University Medicine (NUM) in early 2020 to improve national research activities on the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic. To this end,...
19.
Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al.
EClinicalMedicine
. 2022 Jul;
51:101549.
PMID: 35875815
Background: Post-COVID syndrome (PCS) is an important sequela of COVID-19, characterised by symptom persistence for >3 months, post-acute symptom development, and worsening of pre-existing comorbidities. The causes and public health...
20.
Schmidtke J, Krawczak M
J Community Genet
. 2022 Jun;
13(4):399-401.
PMID: 35661981
Carrier screening for autosomal recessive variants has become a cornerstone of community and public health genetics. While the first carrier screening programs were confined to conditions with relatively high prevalence,...